Literature DB >> 21332028

Melatonin exerts direct inhibitory actions on ACTH responses in the human adrenal gland.

C Campino1, F J Valenzuela, C Torres-Farfan, H E Reynolds, L Abarzua-Catalan, E Arteaga, C Trucco, S Guzmán, G J Valenzuela, M Seron-Ferre.   

Abstract

In nonhuman primates and rodents, melatonin acting directly on the adrenal gland, inhibits glucocorticoid response to ACTH. In these species, an intrinsic adrenal circadian clock is involved in ACTH-stimulated glucocorticoid production. We investigated whether these findings apply to the human adrenal gland by determining i) expression of clock genes in vivo and ii) direct effects of melatonin in ACTH-stimulated adrenal explants over a) expression of the clock genes PER1 (Period 1) mRNA and BMAL1 [Brain-Muscle (ARNT)-like] protein, ACTH-induced steroidogenic acute regulatory protein (StAR), and 3β-hydroxysteroid dehydrogenase (3β-HSD) and b) over cortisol and progesterone production. Adrenal tissue was obtained from 6 renal cancer patients undergoing unilateral nephrectomy-adrenalectomy. Expression of the clock genes PER1, PER2, CRY2 (Cryptochrome 2), CLOCK (Circadian Locomotor Output Cycles Kaput) and BMAL1, was investigated by RT-PCR in a normal adrenal and in an adenoma. In independent experiments, explants from 4 normal adrenals were preincubated in culture medium (6 h) followed by 12 h in: medium alone; ACTH (100 nM); ACTH plus melatonin (100 nM); and melatonin alone. The explants' content of PER1 mRNA (real-time PCR) and StAR, 3β-HSD, BMAL1 (immuno slot-blot), and their cortisol and progesterone production (RIA) were measured. The human adrenal gland expresses the clock genes PER1, PER2, CRY2, CLOCK, and BMAL1. ACTH increased PER1 mRNA, BMAL1, StAR, and 3β-HSD protein levels, and cortisol and progesterone production. Melatonin inhibited these ACTH effects. Our study demonstrates, for the first time, direct inhibitory effects of melatonin upon several ACTH responses in the human adrenal gland. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332028     DOI: 10.1055/s-0031-1271693

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  21 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Circadian clocks in the digestive system.

Authors:  Anneleen Segers; Inge Depoortere
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-02       Impact factor: 46.802

3.  Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?

Authors:  Olivia J Veatch; Suzanne E Goldman; Karen W Adkins; Beth A Malow
Journal:  J Nat Sci       Date:  2015

Review 4.  New hypothesis and treatment targets of depression: an integrated view of key findings.

Authors:  Shangli Cai; Shucai Huang; Wei Hao
Journal:  Neurosci Bull       Date:  2015-01-09       Impact factor: 5.203

5.  Expression of clock-related genes in benign and malignant adrenal tumors.

Authors:  Anna Angelousi; Narjes Nasiri-Ansari; Angeliki Karapanagioti; Georgios Kyriakopoulos; Chrysanthi Aggeli; Giorgos Zografos; Theodosia Choreftaki; Christos Parianos; Theodora Kounadi; Krystallenia Alexandraki; Harpal S Randeva; Gregory Kaltsas; Athanasios G Papavassiliou; Eva Kassi
Journal:  Endocrine       Date:  2020-03-08       Impact factor: 3.633

6.  Neuroimmune endocrine effects of antidepressants.

Authors:  Marco Antonioli; Joanna Rybka; Livia A Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2012-02-07       Impact factor: 2.570

7.  Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep.

Authors:  Maria Seron-Ferre; Henry Reynolds; Natalia Andrea Mendez; Mauricio Mondaca; Francisco Valenzuela; Renato Ebensperger; Guillermo J Valenzuela; Emilio A Herrera; Anibal J Llanos; Claudia Torres-Farfan
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-06       Impact factor: 5.555

Review 8.  Circadian System and Melatonin Hormone: Risk Factors for Complications during Pregnancy.

Authors:  F J Valenzuela; J Vera; C Venegas; F Pino; C Lagunas
Journal:  Obstet Gynecol Int       Date:  2015-03-02

9.  Timed maternal melatonin treatment reverses circadian disruption of the fetal adrenal clock imposed by exposure to constant light.

Authors:  Natalia Mendez; Lorena Abarzua-Catalan; Nelson Vilches; Hugo A Galdames; Carlos Spichiger; Hans G Richter; Guillermo J Valenzuela; Maria Seron-Ferre; Claudia Torres-Farfan
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

Review 10.  Circadian Clocks, Stress, and Immunity.

Authors:  Rebecca Dumbell; Olga Matveeva; Henrik Oster
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.